CRVO 25 year old man - Factor V Leiden Heterozygous
|
|
25 year old man with 1 week vision loss 20/16 OD 20/100 OS - CRVO
Heterozyrous for Factor V Leiden - Required 3 years of Lucentis - VA improved to 20/30. Able to stop therapy
|

CRVO 25 year old man - Heterozygous Factor V Leidenvaatamisi: 48120/100 initial vision. Improved to 20/30 with Lucentis which continued for 3 years, treat and extend, and stopped.     (0 hinnangut)
|
|

CRVO 25 year old man - Heterozygous Factor V Leidenvaatamisi: 38520/100 initial vision. Improved to 20/30 with Lucentis which continued for 3 years, treat and extend, and stopped.     (0 hinnangut)
|
|

CRVO 25 year old man - Heterozygous Factor V Leidenvaatamisi: 43320/100 initial vision. Improved to 20/30 with Lucentis which continued for 3 years, treat and extend, and stopped.     (0 hinnangut)
|
|

CRVO 25 year old man - Heterozygous Factor V Leidenvaatamisi: 37820/100 initial vision. Improved to 20/30 with Lucentis which continued for 3 years, treat and extend, and stopped.     (0 hinnangut)
|
|

CRVO 25 year old man - Heterozygous Factor V Leidenvaatamisi: 41520/100 initial vision. Improved to 20/30 with Lucentis which continued for 3 years, treat and extend, and stopped.     (0 hinnangut)
|
|

CRVO 25 year old man - Heterozygous Factor V Leidenvaatamisi: 38920/100 initial vision. Improved to 20/30 with Lucentis which continued for 3 years, treat and extend, and stopped.     (0 hinnangut)
|
|

CRVO 25 year old man - Heterozygous Factor V Leidenvaatamisi: 46320/100 initial vision. Improved to 20/30 with Lucentis which continued for 3 years, treat and extend, and stopped.     (0 hinnangut)
|
|

CRVO 25 year old man - Heterozygous Factor V Leidenvaatamisi: 38920/100 initial vision. Improved to 20/30 with Lucentis which continued for 3 years, treat and extend, and stopped.     (0 hinnangut)
|
|

CRVO 25 year old man - Heterozygous Factor V Leidenvaatamisi: 38920/100 initial vision. Improved to 20/30 with Lucentis which continued for 3 years, treat and extend, and stopped.     (0 hinnangut)
|
|

CRVO 25 year old man - Heterozygous Factor V Leidenvaatamisi: 37720/100 initial vision. Improved to 20/30 with Lucentis which continued for 3 years, treat and extend, and stopped.     (0 hinnangut)
|
|

CRVO 25 year old man - Heterozygous Factor V Leidenvaatamisi: 38320/100 initial vision. Improved to 20/30 with Lucentis which continued for 3 years, treat and extend, and stopped.     (0 hinnangut)
|
|

CRVO 25 year old man - Heterozygous Factor V Leidenvaatamisi: 38520/100 initial vision. Improved to 20/30 with Lucentis which continued for 3 years, treat and extend, and stopped.     (0 hinnangut)
|
|

CRVO 25 year old man - Heterozygous Factor V Leidenvaatamisi: 38920/100 initial vision. Improved to 20/30 with Lucentis which continued for 3 years, treat and extend, and stopped.     (0 hinnangut)
|
|

CRVO 25 year old man - Heterozygous Factor V Leidenvaatamisi: 37620/100 initial vision. Improved to 20/30 with Lucentis which continued for 3 years, treat and extend, and stopped.     (0 hinnangut)
|
|

CRVO 25 year old man - Heterozygous Factor V Leidenvaatamisi: 40520/100 initial vision. Improved to 20/30 with Lucentis which continued for 3 years, treat and extend, and stopped.     (0 hinnangut)
|
|

CRVO 25 year old man - Heterozygous Factor V Leidenvaatamisi: 38820/100 initial vision. Improved to 20/30 with Lucentis which continued for 3 years, treat and extend, and stopped.     (0 hinnangut)
|
|

CRVO 25 year old man - Heterozygous Factor V Leidenvaatamisi: 35920/100 initial vision. Improved to 20/30 with Lucentis which continued for 3 years, treat and extend, and stopped.     (0 hinnangut)
|
|

CRVO 25 year old man - Heterozygous Factor V Leidenvaatamisi: 41820/100 initial vision. Improved to 20/30 with Lucentis which continued for 3 years, treat and extend, and stopped.     (0 hinnangut)
|
|

CRVO 25 year old man - Heterozygous Factor V Leidenvaatamisi: 37520/100 initial vision. Improved to 20/30 with Lucentis which continued for 3 years, treat and extend, and stopped.     (0 hinnangut)
|
|

CRVO 25 year old man - Heterozygous Factor V Leidenvaatamisi: 34620/100 initial vision. Improved to 20/30 with Lucentis which continued for 3 years, treat and extend, and stopped.     (0 hinnangut)
|
|

CRVO 25 year old man - Heterozygous Factor V Leidenvaatamisi: 36620/100 initial vision. Improved to 20/30 with Lucentis which continued for 3 years, treat and extend, and stopped.     (0 hinnangut)
|
|

CRVO 25 year old man - Heterozygous Factor V Leidenvaatamisi: 39720/100 initial vision. Improved to 20/30 with Lucentis which continued for 3 years, treat and extend, and stopped.     (0 hinnangut)
|
|

CRVO 25 year old man - Heterozygous Factor V Leidenvaatamisi: 38520/100 initial vision. Improved to 20/30 with Lucentis which continued for 3 years, treat and extend, and stopped.     (0 hinnangut)
|
|

CRVO 25 year old man - Heterozygous Factor V Leidenvaatamisi: 41720/100 initial vision. Improved to 20/30 with Lucentis which continued for 3 years, treat and extend, and stopped.     (0 hinnangut)
|
|

CRVO 25 year old man - Heterozygous Factor V Leidenvaatamisi: 36220/100 initial vision. Improved to 20/30 with Lucentis which continued for 3 years, treat and extend, and stopped.     (0 hinnangut)
|
|
|
|
|
|
|
25 year old man with 1 week vision loss 20/16 OD 20/100 OS - CRVO
Heterozyrous for Factor V Leiden - Required 3 years of Lucentis - VA improved to 20/30. Able to stop therapy